Hematology (all articles)
Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis
29 May, 2020 | 03:03h | UTC“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19
27 May, 2020 | 02:21h | UTC
Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic
25 May, 2020 | 01:43h | UTCRelated: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology
Hemostasis Disorders in Critically Ill Patients with COVID-19
18 May, 2020 | 02:08h | UTC
Related Commentary on Twitter
Understanding pathophysiology of hemostasis
What is the link between SARS-CoV-2-associated hypoxia, inflammatory response and both hypercoagulability and endotheliopathy observed in #COVID19 patients?! @yourICM https://t.co/xu0M0FiYcr pic.twitter.com/nm2JB9OKTH— Antibiotic Steward? Bassam Ghanem (@ABsteward) May 16, 2020
[Preprint] Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
15 May, 2020 | 03:50h | UTCEarly Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients – medRxiv
Commentary: Convalescent plasma is safe to treat COVID-19: nationwide study – NBC News
Systematic Review: Plasma from People who Have Recovered from COVID-19 to Treat Individuals with COVID-19
15 May, 2020 | 03:48h | UTC
Coagulation Abnormalities and Thrombosis in Patients with COVID-19
12 May, 2020 | 03:16h | UTCCoagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet
Related Commentary on Twitter
Good to see these welcome recommendations today for diagnosis of clotting and its prevention in patients with severe #COVID19 @TheLancetHaem https://t.co/RrtXSIu2Ne by @MarcelLevi @JerroldLevy and colleagues pic.twitter.com/dU17RIj1f2
— Eric Topol (@EricTopol) May 11, 2020
NCCN Guideline: Hematopoietic Cell Transplantation
10 May, 2020 | 23:53h | UTC
Autopsies Find High Incidence of Venous Thromboembolism in Patients with Covid-19
7 May, 2020 | 09:18h | UTCRelated Study: Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
Observational Study: Anticoagulation Linked to Increased Survival Among Hospitalized Patients with COVID-19
7 May, 2020 | 09:16h | UTCCommentaries: Giving blood thinners to severely ill Covid-19 patients is gaining ground – STAT AND Blood thinners may improve survival among hospitalized COVID-19 patients – Mount Sinai Hospital AND Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients – American College of Cardiology AND Expert reaction to study looking at blood thinners in hospitalised patients with COVID-19 – Science Media Centre
Case Reports: Acute Limb Ischemia in Two Young Patients with COVID-19
7 May, 2020 | 09:15h | UTCAcute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 – The Lancet
Despite Anticoagulation, Patients with Severe SARS-CoV-2 Infection are at Increased Risk of Developing Thrombosis
6 May, 2020 | 03:40h | UTC
Meta-Analysis: Effects of Restrictive vs. Liberal Transfusion Strategies on Longer-term Outcomes After Cardiac Surgery
5 May, 2020 | 03:54h | UTCRelated: Randomized Trial: In Patients Undergoing Cardiac Surgery, A Restrictive Transfusion Approach Does Not Increase the Risk of Acute Kidney Injury (selection of studies on the subject)
Short Review: Coagulopathy Associated with COVID-19
3 May, 2020 | 22:09h | UTCCoagulopathy associated with COVID-19 – Canadian Medical Association Journal
Small Observational Study Suggests Prophylactic LMWH Can Prevent COVID‐19 Disseminated Intravascular Coagulopathy
1 May, 2020 | 03:26h | UTCCOVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology
COVID-19 and Its Implications for Thrombosis and Anticoagulation
30 Apr, 2020 | 04:13h | UTCCOVID-19 and its implications for thrombosis and anticoagulation – Blood
Report: Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19
28 Apr, 2020 | 04:45h | UTC
[Abstract Only] Randomized Trial: Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
23 Apr, 2020 | 09:14h | UTC
WHO Guideline on Use of Ferritin to Assess Iron Status in Individuals and Populations
22 Apr, 2020 | 08:38h | UTCNews Release: WHO guidance helps detect iron deficiency and protect brain development
D‐dimer Levels on Admission to Predict In‐hospital Mortality in Patients with Covid‐19
21 Apr, 2020 | 08:06h | UTC
Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19
21 Apr, 2020 | 08:04h | UTC
Review: COVID-19 and Thrombotic or Thromboembolic Disease
20 Apr, 2020 | 00:18h | UTC
Pathological Evidence of Pulmonary Thrombotic Phenomena in Severe COVID-19
17 Apr, 2020 | 02:24h | UTC* We congratulate the authors for this significant contribution to the understanding of this disease.
Review: Hematological Findings and Complications of COVID‐19
16 Apr, 2020 | 02:40h | UTCHematological findings and complications of COVID‐19 – American Journal of Hematology
COVID-19 and Coagulopathy: Frequently Asked Questions
16 Apr, 2020 | 02:39h | UTCCOVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology
Related: Possible Algorithm to Empiric Anticoagulation in COVID-19 Based on D-Dimer (3 guidance papers with different approaches)